New Gene Pathway Found to Prevent Gut Inflammation
The COMPASS pathway governs regulatory T cells, preventing lethal immune responses to beneficial bacteria in the gut.
Updated on Oct. 29, 2026 in Life Sciences
Live Poll
Do you believe new discoveries in immune regulation will lead to effective treatments for autoimmune diseases?
Researchers at St. Jude Children's Research Hospital have identified the COMPASS gene-regulatory pathway as a critical mechanism for maintaining gut immune tolerance. This research, published in Science Advances, demonstrates that the Wdr82 gene is essential for regulatory T cell function, with its loss leading to severe intestinal inflammation in mouse models.
Why it matters
Understanding this pathway clarifies how the immune system distinguishes between beneficial gut microbiota and harmful threats. This discovery opens a new area of study into how genetic variations in regulatory T cells may contribute to inflammatory intestinal conditions.
The study measured the impact of Wdr82 deletion against wild-type control groups to demonstrate the gene's necessity for immune suppression. Researchers confirmed that antibiotic-induced depletion of gut bacteria prevents inflammation in Wdr82-deficient mice, indicating the gene's primary role is managing tolerance toward microbiota.
The players
St. Jude Children's Research Hospital
A pediatric treatment and research facility focused on catastrophic diseases, with a specialized immunology department that utilizes high-throughput genomic screening.
The details
Scientists utilized a CRISPR-Cas9 screen—a genome-editing tool that acts as molecular scissors to disable specific genes—to isolate Wdr82 as a primary component of the COMPASS pathway. This pathway regulates gene expression by modifying chromatin, the protein-DNA complex that determines which genes are active within a cell. In the study, the loss of Wdr82 disproportionately impaired regulatory T cells, which are specialized immune cells that suppress inflammatory responses, compared to the inflammatory effector T cells that attack pathogens.
Timeline
October 28, 2026: The research findings were published in the journal Science Advances.
The Tech Race
This discovery places St. Jude’s at the forefront of mapping how specific gene-regulatory pathways dictate the survival of immune cell subtypes. It builds upon established knowledge of the microbiome to define the molecular control switches that keep systemic inflammation in check.
This research is currently in the experimental stage and has no immediate clinical application for patients. Future studies will need to determine if genetic variants in human patients influence the efficacy of these T-cell subtypes during chronic inflammation.
The takeaway
The study confirms that the COMPASS pathway is a vital, non-redundant check on the immune system's tolerance for gut bacteria. Researchers will now look for human genetic variations in this pathway to see if they correlate with unexplained cases of inflammatory bowel disease.
Further reading
For more on the latest research in the field, explore the Life Sciences archive.
Source note: This article includes information reported by News-Medical.
Live Poll
Do you believe new discoveries in immune regulation will lead to effective treatments for autoimmune diseases?
